Zobrazeno 1 - 10
of 1 396
pro vyhledávání: '"Van Venrooij, W"'
Autor:
Reichlin, M.1, van Venrooij, W. J.2
Publikováno v:
Clinical & Experimental Immunology. Feb1991, Vol. 83 Issue 2, p286-290. 5p.
Publikováno v:
Cell Death & Differentiation. Jan2000, Vol. 7 Issue 1, p131. 3p.
Autor:
Kannappan, Renuka1 (AUTHOR) renuka.kannappan@tuhs.temple.edu, Kumar, Raagni1 (AUTHOR), Cichelli, Kimberly2 (AUTHOR), Brent, Lawrence H.2 (AUTHOR) renuka.kannappan@tuhs.temple.edu
Publikováno v:
Journal of Clinical Medicine. Jul2024, Vol. 13 Issue 14, p4055. 25p.
Autor:
Sadraeian, Mohammad1 (AUTHOR) mohammad.sadraeian@uts.edu.au, Maleki, Reza2 (AUTHOR), Moraghebi, Mahta2 (AUTHOR), Bahrami, Abasalt3 (AUTHOR)
Publikováno v:
Molecules. Jul2024, Vol. 29 Issue 13, p1-22. 22p.
Publikováno v:
Annals of the Rheumatic Diseases; Aug1988, Vol. 47 Issue 8, p634-641, 8p, 3 Charts
Autor:
Loh TJ; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Australia., Lim JJ; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Australia., Jones CM; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Australia., Dao HT; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Australia., Tran MT; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Australia., Baker DG; Janssen Research & Development, LLC, Horsham, Philadelphia, PA, USA., La Gruta NL; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Australia., Reid HH; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Australia. hugh.reid@monash.edu., Rossjohn J; Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Australia. jamie.rossjohn@monash.edu.; Institute of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff, UK. jamie.rossjohn@monash.edu.
Publikováno v:
Nature communications [Nat Commun] 2024 Jul 23; Vol. 15 (1), pp. 6201. Date of Electronic Publication: 2024 Jul 23.
Autor:
Raposo B; Department of Medicine, Division of Rheumatology, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Klareskog L; Department of Medicine, Division of Rheumatology, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Robinson WH; Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.; VA Palo Alto Health Care System, Palo Alto, CA, USA., Malmström V; Department of Medicine, Division of Rheumatology, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. vivianne.malmstrom@ki.se., Grönwall C; Department of Medicine, Division of Rheumatology, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Publikováno v:
Nature reviews. Rheumatology [Nat Rev Rheumatol] 2024 Jul; Vol. 20 (7), pp. 399-416. Date of Electronic Publication: 2024 Jun 10.
Publikováno v:
Arthritis Research & Therapy, 6, pp. S7-S7
Arthritis Research & Therapy
Arthritis Research & Therapy, 6, S7-S7
Europe PubMed Central
Arthritis Research & Therapy
Arthritis Research & Therapy, 6, S7-S7
Europe PubMed Central
Contains fulltext : 60098.pdf (Publisher’s version ) (Open Access)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmc_dedup___::293add262767bd1081fe717afb9b52d2
https://hdl.handle.net/2066/60098
https://hdl.handle.net/2066/60098
To determine the prevalence of myositis specific autoantibodies (MSAs) and several myositis associated autoantibodies (MAAs) in a large group of patients with myositis.A total of 417 patients with myositis from 11 European countries (198 patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6969bebc2b90fd0ccbaad8368244a313
https://europepmc.org/articles/PMC1753798/
https://europepmc.org/articles/PMC1753798/
Autor:
van Jaarsveld, C. H., ter Borg, E. J., Jacobs, J. W., Schellekens, G. A., Gmelig-Meyling, F. H., van Booma-Frankfort, C., de Jong, B. A., van Venrooij, W. J., Bijlsma, J. W.
Publikováno v:
Clinical and experimental rheumatology, 17(6), 689-697. Clinical and Experimental Rheumatology S.A.S.
To study the prognostic value of the antiperinuclear factor (APF), determined by an indirect immunofluorescence test (IIF) and a recently developed anti-citrullinated cyclic peptide (CCP) ELISA, in combination with rheumatoid factor (RF) status, in e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::12c50e3d06dd9992dc5509a538527fbd
https://pure.amc.nl/en/publications/the-prognostic-value-of-the-antiperinuclear-factor-anticitrullinated-peptide-antibodies-and-rheumatoid-factor-in-early-rheumatoid-arthritis(1f31d291-a6de-48ca-9b72-93221905da66).html
https://pure.amc.nl/en/publications/the-prognostic-value-of-the-antiperinuclear-factor-anticitrullinated-peptide-antibodies-and-rheumatoid-factor-in-early-rheumatoid-arthritis(1f31d291-a6de-48ca-9b72-93221905da66).html